SOLVENTUM CORP (SOLV) Fundamental Analysis & Valuation
NYSE:SOLV • US83444M1018
Current stock price
64.2869 USD
-1.4 (-2.14%)
Last:
This SOLV fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. SOLV Profitability Analysis
1.1 Basic Checks
- SOLV had positive earnings in the past year.
- SOLV had a positive operating cash flow in the past year.
- In the past 5 years SOLV has always been profitable.
- In the past 5 years SOLV always reported a positive cash flow from operatings.
1.2 Ratios
- SOLV's Return On Assets of 10.89% is amongst the best of the industry. SOLV outperforms 92.59% of its industry peers.
- The Return On Equity of SOLV (30.82%) is better than 97.88% of its industry peers.
- With a decent Return On Invested Capital value of 5.40%, SOLV is doing good in the industry, outperforming 76.19% of the companies in the same industry.
- The Average Return On Invested Capital over the past 3 years for SOLV is in line with the industry average of 9.31%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.89% | ||
| ROE | 30.82% | ||
| ROIC | 5.4% |
ROA(3y)7.95%
ROA(5y)8.82%
ROE(3y)19.51%
ROE(5y)16.42%
ROIC(3y)8.39%
ROIC(5y)9.89%
1.3 Margins
- SOLV's Profit Margin of 18.69% is amongst the best of the industry. SOLV outperforms 94.71% of its industry peers.
- In the last couple of years the Profit Margin of SOLV has grown nicely.
- The Operating Margin of SOLV (8.53%) is better than 76.19% of its industry peers.
- In the last couple of years the Operating Margin of SOLV has declined.
- The Gross Margin of SOLV (53.57%) is comparable to the rest of the industry.
- In the last couple of years the Gross Margin of SOLV has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.53% | ||
| PM (TTM) | 18.69% | ||
| GM | 53.57% |
OM growth 3Y-25.46%
OM growth 5YN/A
PM growth 3Y4.2%
PM growth 5YN/A
GM growth 3Y-2.47%
GM growth 5YN/A
2. SOLV Health Analysis
2.1 Basic Checks
- SOLV has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- SOLV has more shares outstanding than it did 1 year ago.
- The debt/assets ratio for SOLV has been reduced compared to a year ago.
2.2 Solvency
- SOLV has an Altman-Z score of 1.72. This is a bad value and indicates that SOLV is not financially healthy and even has some risk of bankruptcy.
- The Altman-Z score of SOLV (1.72) is comparable to the rest of the industry.
- SOLV has a Debt/Equity ratio of 1.00. This is a neutral value indicating SOLV is somewhat dependend on debt financing.
- SOLV has a worse Debt to Equity ratio (1.00) than 74.60% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.72 |
ROIC/WACC0.5
WACC10.78%
2.3 Liquidity
- SOLV has a Current Ratio of 1.23. This is a normal value and indicates that SOLV is financially healthy and should not expect problems in meeting its short term obligations.
- With a Current ratio value of 1.23, SOLV is not doing good in the industry: 82.54% of the companies in the same industry are doing better.
- A Quick Ratio of 0.89 indicates that SOLV may have some problems paying its short term obligations.
- SOLV has a Quick ratio of 0.89. This is amonst the worse of the industry: SOLV underperforms 82.01% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.23 | ||
| Quick Ratio | 0.89 |
3. SOLV Growth Analysis
3.1 Past
- SOLV shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.82%.
- The Earnings Per Share has been growing slightly by 4.46% on average over the past years.
- SOLV shows a small growth in Revenue. In the last year, the Revenue has grown by 0.86%.
- SOLV shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.79% yearly.
EPS 1Y (TTM)-8.82%
EPS 3Y4.46%
EPS 5YN/A
EPS Q2Q%11.35%
Revenue 1Y (TTM)0.86%
Revenue growth 3Y0.79%
Revenue growth 5YN/A
Sales Q2Q%-3.66%
3.2 Future
- The Earnings Per Share is expected to grow by 9.04% on average over the next years. This is quite good.
- The Revenue is expected to grow by 0.77% on average over the next years.
EPS Next Y7.68%
EPS Next 2Y8.46%
EPS Next 3Y9.04%
EPS Next 5YN/A
Revenue Next Year-1.28%
Revenue Next 2Y1.15%
Revenue Next 3Y2.07%
Revenue Next 5Y0.77%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. SOLV Valuation Analysis
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 10.54 indicates a reasonable valuation of SOLV.
- Compared to the rest of the industry, the Price/Earnings ratio of SOLV indicates a rather cheap valuation: SOLV is cheaper than 91.53% of the companies listed in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 25.54, SOLV is valued rather cheaply.
- SOLV is valuated reasonably with a Price/Forward Earnings ratio of 9.79.
- 94.18% of the companies in the same industry are more expensive than SOLV, based on the Price/Forward Earnings ratio.
- When comparing the Price/Forward Earnings ratio of SOLV to the average of the S&P500 Index (22.70), we can say SOLV is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.54 | ||
| Fwd PE | 9.79 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SOLV indicates a rather cheap valuation: SOLV is cheaper than 84.13% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 12.97 |
4.3 Compensation for Growth
- SOLV's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- The decent profitability rating of SOLV may justify a higher PE ratio.
PEG (NY)1.37
PEG (5Y)N/A
EPS Next 2Y8.46%
EPS Next 3Y9.04%
5. SOLV Dividend Analysis
5.1 Amount
- SOLV does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
SOLV Fundamentals: All Metrics, Ratios and Statistics
NYSE:SOLV (3/24/2026, 10:19:08 AM)
64.2869
-1.4 (-2.14%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-26 2026-02-26/amc
Earnings (Next)05-06 2026-05-06
Inst Owners73.53%
Inst Owner ChangeN/A
Ins Owners0.15%
Ins Owner Change0.31%
Market Cap11.15B
Revenue(TTM)8.32B
Net Income(TTM)1.56B
Analysts75.24
Price Target91.16 (41.8%)
Short Float %2.37%
Short Ratio3.07
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.79%
Min EPS beat(2)2.66%
Max EPS beat(2)2.92%
EPS beat(4)4
Avg EPS beat(4)7.06%
Min EPS beat(4)2.66%
Max EPS beat(4)15.09%
EPS beat(8)8
Avg EPS beat(8)8.33%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.02%
Min Revenue beat(2)-0.15%
Max Revenue beat(2)0.19%
Revenue beat(4)2
Avg Revenue beat(4)0.17%
Min Revenue beat(4)-0.15%
Max Revenue beat(4)0.68%
Revenue beat(8)2
Avg Revenue beat(8)-0.41%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)4.13%
EPS NQ rev (1m)-8.17%
EPS NQ rev (3m)-8.93%
EPS NY rev (1m)1.46%
EPS NY rev (3m)1.11%
Revenue NQ rev (1m)0.9%
Revenue NQ rev (3m)1.06%
Revenue NY rev (1m)2.01%
Revenue NY rev (3m)2.38%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.54 | ||
| Fwd PE | 9.79 | ||
| P/S | 1.34 | ||
| P/FCF | N/A | ||
| P/OCF | 30.23 | ||
| P/B | 2.21 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.97 |
EPS(TTM)6.1
EY9.49%
EPS(NY)6.57
Fwd EY10.22%
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)2.13
OCFY3.31%
SpS47.99
BVpS29.1
TBVpS-18.72
PEG (NY)1.37
PEG (5Y)N/A
Graham Number63.2
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.89% | ||
| ROE | 30.82% | ||
| ROCE | 6.36% | ||
| ROIC | 5.4% | ||
| ROICexc | 5.87% | ||
| ROICexgc | 30.39% | ||
| OM | 8.53% | ||
| PM (TTM) | 18.69% | ||
| GM | 53.57% | ||
| FCFM | N/A |
ROA(3y)7.95%
ROA(5y)8.82%
ROE(3y)19.51%
ROE(5y)16.42%
ROIC(3y)8.39%
ROIC(5y)9.89%
ROICexc(3y)8.79%
ROICexc(5y)10.16%
ROICexgc(3y)43.79%
ROICexgc(5y)51.79%
ROCE(3y)9.88%
ROCE(5y)11.65%
ROICexgc growth 3Y-18.46%
ROICexgc growth 5YN/A
ROICexc growth 3Y-20.41%
ROICexc growth 5YN/A
OM growth 3Y-25.46%
OM growth 5YN/A
PM growth 3Y4.2%
PM growth 5YN/A
GM growth 3Y-2.47%
GM growth 5YN/A
F-Score6
Asset Turnover0.58
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 4.2 | ||
| Cap/Depr | 77.51% | ||
| Cap/Sales | 4.55% | ||
| Interest Coverage | 1.61 | ||
| Cash Conversion | 30.78% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.23 | ||
| Quick Ratio | 0.89 | ||
| Altman-Z | 1.72 |
F-Score6
WACC10.78%
ROIC/WACC0.5
Cap/Depr(3y)65.89%
Cap/Depr(5y)57.5%
Cap/Sales(3y)4.23%
Cap/Sales(5y)3.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.82%
EPS 3Y4.46%
EPS 5YN/A
EPS Q2Q%11.35%
EPS Next Y7.68%
EPS Next 2Y8.46%
EPS Next 3Y9.04%
EPS Next 5YN/A
Revenue 1Y (TTM)0.86%
Revenue growth 3Y0.79%
Revenue growth 5YN/A
Sales Q2Q%-3.66%
Revenue Next Year-1.28%
Revenue Next 2Y1.15%
Revenue Next 3Y2.07%
Revenue Next 5Y0.77%
EBIT growth 1Y-31.93%
EBIT growth 3Y-24.87%
EBIT growth 5YN/A
EBIT Next Year21.89%
EBIT Next 3Y11.54%
EBIT Next 5YN/A
FCF growth 1Y-101.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-68.86%
OCF growth 3Y-39.65%
OCF growth 5YN/A
SOLVENTUM CORP / SOLV Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for SOLVENTUM CORP?
ChartMill assigns a fundamental rating of 4 / 10 to SOLV.
What is the valuation status of SOLVENTUM CORP (SOLV) stock?
ChartMill assigns a valuation rating of 6 / 10 to SOLVENTUM CORP (SOLV). This can be considered as Fairly Valued.
Can you provide the profitability details for SOLVENTUM CORP?
SOLVENTUM CORP (SOLV) has a profitability rating of 7 / 10.
How financially healthy is SOLVENTUM CORP?
The financial health rating of SOLVENTUM CORP (SOLV) is 1 / 10.